Breakfast News: We’re Right There With You

The Nasdaq-100 fell nearly 5% on Friday, its third 10% correction this year, a sharp reminder of how fast sentiment can flip. Despite the drawdown, the index has nearly doubled over three years, which frames Friday's selloff as a violent pullback inside a larger uptrend rather than proof the trend has ended (interpretation, not a stated forecast).

The week ahead brings a dense earnings slate. Apple (AAPL), Shopify (SHOP), AMD (AMD), and Berkshire Hathaway (BRK.A, BRK.B) all report. With the Nasdaq-100 just off a near-5% single-day drop, results from AAPL, SHOP, and AMD land when index-heavy growth names are already under pressure. Berkshire's report adds a counterweight from a different corner of the market.

In single-stock news, Kiniksa Pharmaceuticals (KNSA) is drawing attention as its heart drug Arcalyst is projected to become a blockbuster, with sales above $1 billion. That figure is a standalone catalyst that doesn't depend on index direction.

The source's guidance is defensive: stay invested through volatility using dollar-cost averaging and diversification, and keep focus on long-term plans instead of election-driven trading.